
NeuroMetrix NURO
Geschäftsbericht 2024
hinzugefügt 31.03.2025
Land |
|
IPO-Jahr |
2004 |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBAL |
Anteile |
1.97 M |
Marktkapitalisierung |
$ 9.02 M |
EBITDA (LTM) |
$ -7.81 M |
P/E (LTM) |
- |
P/S (LTM) |
2.47 |
EPS (LTM) |
-4.82 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 19.51 | 2.12 % | $ 9.95 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 195.0 | 0.49 % | $ 56.1 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 8.13 | -5.9 % | $ 164 M | Nasdaq Capital Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Harvard Bioscience
HBIO
|
$ 0.66 | -0.9 % | $ 28 M | Nasdaq Global Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Repro Med Systems
KRMD
|
$ 5.58 | -3.96 % | $ 254 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 77.69 | -1.42 % | $ 40.4 B | NYSE | ||
|
AtriCure
ATRC
|
$ 39.19 | -0.94 % | $ 1.84 B | Nasdaq Global Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 86.9 | -1.41 % | $ 5.06 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 139.1 | -2.5 % | $ 3.39 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 4.54 | 1.23 % | $ 25 K | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 175.59 | -1.04 % | $ 5.48 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.64 | -1.56 % | $ 516 M | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.37 | -0.72 % | $ 16.2 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 4.78 | -2.15 % | $ 49.6 M | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 111.02 | -1.67 % | $ 5.38 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 80.78 | -0.39 % | $ 1.81 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 80.15 | - | $ 4.03 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.46 | -5.58 % | $ 175 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 127.63 | -1.87 % | $ 6.8 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 562.18 | -0.74 % | $ 200 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.37 | -2.27 % | $ 176 M | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.09 | 4.69 % | $ 21.3 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 6.23 % | $ 23.1 M | NYSE American | ||
|
STERIS plc
STE
|
$ 251.21 | -0.91 % | $ 24.8 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 21.74 | 0.09 % | $ 3.74 B | NYSE | ||
|
Stereotaxis
STXS
|
$ 2.32 | 0.65 % | $ 187 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 37.63 | -2.21 % | $ 124 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 32.4 M | Nasdaq Capital Market | ||
|
Pulse Biosciences
PLSE
|
$ 13.26 | -3.46 % | $ 637 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 57.34 | 2.47 % | $ 208 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 245.02 | 1.75 % | $ 35.8 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.33 | -0.87 % | $ 2.3 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 163.5 | -0.22 % | $ 9.11 M | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 23.86 | -1.32 % | $ 1.1 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.77 | -0.7 % | $ 23.1 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 23.45 | 1.56 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 123.04 | 0.79 % | $ 5.76 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 276.44 | 0.44 % | $ 20.2 B | NYSE,SPB |